Health
Could Coronavirus Variants Boost Pfizer’s Vaccine Sales By 50%? – Motley Fool
Probably not in the way some might think.
Fifteen billion dollars: That’s how much Pfizer(NYSE:PFE)projected last month in its Q4 update that it will make this year from its COVID-19 vaccine, BNT162b2. Sure, the company splits profits equally with its partner, BioNTech(NASDAQ:BNTX), but we’re still talking about a lot of money.
The actual amount will almost surely be even higher. Since Pfizer’s update, the U.S. government has ordered another 100 million doses of BNT162b2. But could Pfizer’s revenue from the vaccine be 50% higher because…
-
Noosa News23 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News20 hours agoNoosa Council targeted in fraud
-
Noosa News20 hours agoDavid’s neighbour died alone. He now knows what comes next
-
General22 hours agoACT family violence victims ‘waiting 3 or 4 days’ for help, inquiry hears